GYKI-16638 is a novel antiarrhythmic agent. GYKI-16638 has an in vivo antiarrhythmic effect, comparable to that of D-sotalol. GYKI 16638 in human ventricular muscle shows combined Class IB and Class III antiarrhythmic properties, resembling the electrophysiological manifestation seen after chronic amiodarone treatment. References: Mátyus P, Varga I, Rettegi T, Simay A, Kállay N, Károlyházy L, Kocsis A, Varró A, Pénzes I, Papp JG. Novel antiarrhythmic compounds with combined class IB and class III mode of action. Curr Med Chem. 2004 Jan;11(1):61-9. Review. PubMed PMID: 14754426.

纯度：≥98%

CAS：307556-59-8